Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

RREGEN BIOPHARMA, INC.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
R

REGEN BIOPHARMA, INC.

$0.01Close · Jul 30, 2026
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $59.07K. Net result −$637.79K. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $59.07K. Running result $59.07K. Revenue: $59.07K.
  • Cost of revenue: −$0.001K. Running result $59.06K.
  • Gross profit: $59.06K. Running result $59.06K.
  • Research and Development: $0. Running result $59.06K.
  • General and Administrative: −$13.84K. Running result $45.22K.
  • Consulting and Professional Fees: −$20.69K. Running result $24.53K.
  • Rent: $0. Running result $24.53K.
  • Operating income: $24.53K. Running result $24.53K.
  • Other expense: −$662.31K. Running result −$637.79K.
  • Pre-tax loss: −$637.79K. Running result −$637.79K.
  • Income tax benefit: $0. Running result −$637.79K.
  • Net loss: −$637.79K. Running result −$637.79K.